NST-4016

· NorthSea Therapeutics B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NST-4016, covering 2019-11-04 to 2019-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval [Phase 1]